Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial.

Kjaergaard, Krista Dybtved; Peters, Christian Daugaard; Jespersen, Bente; Tietze, Ida Nørager; Madsen, Jens Kristian; Pedersen, Birgitte Bang; Novosel, Marija Kristina; Laursen, Kathrine Skaaning; Bibby, Bo Martin; Strandhave, Charlotte; Jensen, Jens Dam

Kjaergaard, Krista Dybtved; Peters, Christian Daugaard; Jespersen, Bente; Tietze, Ida Nørager; Madsen, Jens Kristian; Pedersen, Birgitte Bang; Novosel, Marija Kristina; Laursen, Kathrine Skaaning; Bibby, Bo Martin; Strandhave, Charlotte; Jensen, Jens Dam.

Afiliação

Kjaergaard KD; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: krista@ki.au.dk.
Peters CD; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Jespersen B; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Tietze IN; Department of Internal Medicine, Regional Hospital Viborg, Viborg, Denmark.
Madsen JK; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Pedersen BB; Department of Nephrology, Aalborg University Hospital, Aalborg, Denmark.
Novosel MK; Department of Medicine, Fredericia Hospital, Fredericia, Denmark.
Laursen KS; Department of Nephrology, Aalborg University Hospital, Aalborg, Denmark.
Bibby BM; Department of Public Health, Institute of Biostatistics, Aarhus University, Aarhus, Denmark.
Strandhave C; Department of Nephrology, Aalborg University Hospital, Aalborg, Denmark.
Jensen JD; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Am J Kidney Dis ; 64(6): 892-901, 2014 Dec.

Article em En | MEDLINE | ID: mdl-25011693

Assuntos

Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico; Angiotensinas/antagonistas & inibidores; Progressão da Doença; Rim/fisiologia; Diálise Renal/tendências; Insuficiência Renal Crônica/terapia; Idoso; Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia; Angiotensinas/fisiologia; Compostos de Bifenilo/uso terapêutico; Método Duplo-Cego; Feminino; Seguimentos; Humanos; Irbesartana; Rim/efeitos dos fármacos; Masculino; Pessoa de Meia-Idade; Diálise Renal/efeitos adversos; Insuficiência Renal Crônica/fisiopatologia; Tetrazóis/uso terapêutico

Palavras-chave

Adult; GFR decline; SAFIR (Saving Residual Renal Function in Hemodialysis Patients Receiving Irbesartan) trial; albuminuria; aldosterone; angiotensin II; angiotensin II receptor blocker; anuria; double-blinded; glomerular filtration rate (GFR); hemodialysis (HD); investigator-initiated; irbesartan; multicenter study; placebo; preservation of residual renal function; randomized controlled trial; renin; residual renal function; urine volume

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiotensinas / Diálise Renal / Progressão da Doença / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Insuficiência Renal Crônica / Rim Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Kidney Dis Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google